Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind controlled trial of Kaempferia parviflora versus betahistine in chronic vertigo
TCTR20220829001Phase 3Completed
- Sponsor
- Agricultural Research Development Agency
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of kaempferia parviflora in vertigo, sponsored by Agricultural Research Development Agency. Started Mar 2023; status: completed.
02
Drugs
kaempferia parviflora
03
Conditions
vertigo
Beyond the preview
Go deeper on TCTR20220829001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220829001.